Skip to content
ppharmaranks
Menu

Best treatments for candidiasis

3 products may treat candidiasis, spanning FDA drug classes such as azole antifungal, nucleoside analog antifungal. The current highest-rated option is voriconazole. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 3 drugs we list for candidiasis, 2 are available as lower-cost generics, spanning classes such as azole antifungal, nucleoside analog antifungal. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for candidiasis — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Top-rated picks for candidiasis: 1. Voriconazole · 2. Vfend · 3. Ancobon

Top-rated treatments for candidiasis, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100$56View →
264/100$56View →
3Not yet ratedView →

Narrow by drug class

Explore the class hubs: azole antifungal

Full ranking · 3 treatments

Frequently asked

What treats candidiasis?
Our catalog lists 3 products that may treat candidiasis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is voriconazole.
What is the best-rated treatment for candidiasis?
By our independent recall-safety rating — not an efficacy measure — voriconazole ranks highest among the products we list for candidiasis. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat candidiasis?
Treatments for candidiasis span FDA drug classes including azole antifungal, nucleoside analog antifungal. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.